Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
SciFluor Life Sciences, a biotech firm focused on improving the pharmacokinetic properties of drugs, has launched with $5 million in first-round funding from Allied Minds. SciFluor is based on fluorination technology developed in the lab of Harvard University chemist Tobias Ritter, who is also the company’s chief technical officer. Ritter and colleagues have developed a way of introducing fluorine into a molecule without having to rework a synthetic pathway. SciFluor says fluorination can improve a compound’s metabolic stability, potency, binding affinity, and ability to cross the blood-brain barrier.
This article has been sent to the following recipient: